1. Home
  2. MDCX vs GNTA Comparison

MDCX vs GNTA Comparison

Compare MDCX & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medicus Pharma Ltd.

MDCX

Medicus Pharma Ltd.

HOLD

Current Price

$0.42

Market Cap

23.6M

Sector

N/A

ML Signal

HOLD

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.78

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDCX
GNTA
Founded
2008
2014
Country
United States
Italy
Employees
16
13
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.6M
19.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MDCX
GNTA
Price
$0.42
$1.78
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$14.50
N/A
AVG Volume (30 Days)
1.7M
263.6K
Earning Date
05-11-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.25
$0.55
52 Week High
$3.69
$10.00

Technical Indicators

Market Signals
Indicator
MDCX
GNTA
Relative Strength Index (RSI) 53.76 54.32
Support Level $0.38 $1.31
Resistance Level $0.52 $2.12
Average True Range (ATR) 0.05 0.17
MACD 0.00 -0.05
Stochastic Oscillator 55.92 21.95

Price Performance

Historical Comparison
MDCX
GNTA

About MDCX Medicus Pharma Ltd.

Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: